Celltrion receives Korean MFDS approval to initiate trial of Covid-19 antiviral antibody treatment candidate

Celltrion has secured Korean MFDS approval to initiate trial of Covid-19 antiviral antibody treatment candidate. (Credit: dianakuehn30010 from Pixabay)